12, ISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
| kobo.com E-Book zum download. Versandkosten: EUR 0.00 Details... |
ISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
| VitalSource.com 9783319249315,9783319249322,3319249312,3319249320. Versandkosten: EUR 0.00 Details... |
2012, ISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
| kobo.com E-Book zum download. Versandkosten: EUR 0.00 Details... |
ISBN: 9783319249322
Biomedicine; Cancer Research Lung cancer, Genomics, Therapeutic Implications, Stem Cells, Small Cell Lung Cancer, Radiation Therapy Books eBook, Springer Nature
| Springer.com Versandkosten:zzgl. Versandkosten. Details... |
2015, ISBN: 9783319249322
eBooks, eBook Download (PDF), 1st ed. 2016, [PU: Springer International Publishing], Springer International Publishing, 2015
| lehmanns.de Versandkosten:Download sofort lieferbar. (EUR 0.00) Details... |
12, ISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
Aamir Ahmad:
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management - neues BuchISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
2012
ISBN: 9783319249322
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeut… Mehr…
ISBN: 9783319249322
Biomedicine; Cancer Research Lung cancer, Genomics, Therapeutic Implications, Stem Cells, Small Cell Lung Cancer, Radiation Therapy Books eBook, Springer Nature
2015, ISBN: 9783319249322
eBooks, eBook Download (PDF), 1st ed. 2016, [PU: Springer International Publishing], Springer International Publishing, 2015
Bibliographische Daten des bestpassenden Buches
| Autor: | |
| Titel: | |
| ISBN-Nummer: |
Detailangaben zum Buch - Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
EAN (ISBN-13): 9783319249322
Erscheinungsjahr: 2016
Herausgeber: Springer International Publishing
Buch in der Datenbank seit 2017-04-16T22:44:20+02:00 (Berlin)
Detailseite zuletzt geändert am 2022-10-12T20:13:54+02:00 (Berlin)
ISBN/EAN: 9783319249322
ISBN - alternative Schreibweisen:
978-3-319-24932-2
Alternative Schreibweisen und verwandte Suchbegriffe:
Titel des Buches: cancer management, clinical medicine
Daten vom Verlag:
Autor/in: Aamir Ahmad; Shirish M. Gadgeel
Titel: Advances in Experimental Medicine and Biology; Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
Verlag: Springer; Springer International Publishing
231 Seiten
Erscheinungsjahr: 2015-12-24
Cham; CH
Sprache: Englisch
96,29 € (DE)
99,00 € (AT)
118,00 CHF (CH)
Available
X, 231 p. 22 illus., 21 illus. in color.
EA; E107; eBook; Nonbooks, PBS / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Lung cancer; Genomics; Therapeutic Implications; Stem Cells; Small Cell Lung Cancer; Radiation Therapy; B; Cancer Biology; Biomedical and Life Sciences; BB
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
1 Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.-2 Emerging Biomarkers in Personalized Therapy of Lung Cancer.-3 Epithelial mesenchymal transition in aggressive lung cancers.-4 The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.-5 The microenvironment of lung cancer and therapeutic implications.-6 Epigenetics in Personalized Management of Lung Cancers.-7 Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.-8 Nanomedicine for Treatment of Lung Cancer.-9 Personalized Therapy of Small Cell Lung Cancer.-10 Personalized Radiation Therapy for Lung Cancer.-11 Current Clinical Management in the era of personalized therapy.-11 Personalized Therapy of Non-Small Cell Lung Cancer.
is a Professor in the Department of Oncology at Karmanos Cancer Institute/Wayne State University in Detroit. He is also the co-leader of the Molecular Therapeutics Program of Karmanos Cancer Institute and the Leader of the Multidisciplinary Thoracic Oncology team. He is
Aamir Ahmad, PhD, Breast Cancer Metastasis and Drug Resistance Lung Cancer and Personalized Medicine: Current Knowledge and Therapies. Shirish M. GadgeelThis, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.
Provides a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans Addresses statistics and epidemiology of lung cancer, along with the incidence of lung cancer in non-smokers Evaluates the state of current therapies–immune, targeted therapies against EGFR TKIs, KRAS, ALK and the associated challenges, especially resistance mechanisms
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9783319797021 Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management (Shirish M. Gadgeel)
< zum Archiv...